The effects of dobutamine on renal sympathetic activity in human heart failure

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 5, 2008, Pages 434-436

  Al Hesayen, Abdul ^a   Parker, John D ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Dobutamine; Heart failure; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; NORADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN; KIDNEY; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTOLIC HEART FAILURE; ADRENERGIC SYSTEM; DOSE RESPONSE; INNERVATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; MIDDLE AGED; RENAL PLASMA FLOW; SYMPATHETIC NERVOUS SYSTEM;

EID: 55949130403     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181684026     Document Type: Article

References (23)

1. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61-67.
2. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation. 2004;110:1514-1517.
3. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000; 102:203-210.
4. Dries DL, Exner DV, Domanski MJ, et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35:681-689.
5. Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986; 73:615-621.
6. Schrier RW, Fassett RG, Ohara M, et al. Pathophysiology of renal fluid retention. Kidney Int Suppl. 1998;67:S127-132.
7. Al-Hesayen A and Parker JD. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure. Circulation. 2004;109: 2862-2865.
8. Oberg B and Thoren P. Studies on left ventricular receptors, signalling in non-medullated vagal afferents. Acta Physiol Scand. 1972;85:145-163.
9. Al-Hesayen A, Azevedo ER, Newton GE, et al. The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure. J Am Coll Cardiol. 2002;39:1269-1274.
10. Esler MD, Jennings GL, Johns J, et al. Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. J Hypertens Suppl. 1984;2:S123-125.
11. Esler M, Jennings G, Korner P, et al. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol. 1984;247:E21-28.
12. DiBona GF and Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197.
13. DiBona GF. Physiology in perspective: The Wisdom of the Body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol. 2005;289: R633-641.
14. Thoren P. Role of cardiac vagal C-fibers in cardiovascular control. Rev Physiol Biochem Pharmacol. 1979;86:1-94.
15. Thoren PN. Characteristics of left ventricular receptors with non-medullated vagal afferents in cats. Circ Res. 1977;40:415-421.
16. Middlekauff HR, Nitzsche EU, Hamilton MA, et al. Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure. A positron emission tomography study. Circulation. 1995;92:395-401.
17. Ruffolo RR Jr. The pharmacology of dobutamine. Am J Med Sci. 1987; 294:244-248.
18. DiBona GF and Sawin LL. Effect of metoprolol administration on renal sodium handling in experimental congestive heart failure. Circulation. 1999;100:82-86.
19. Miki K, Hayashida Y, and Shiraki K. Cardiac-renal-neural reflex plays a major role in natriuresis induced by left atrial distension. Am J Physiol. 1993;264:R369-375.
20. Miki K, Hayashida Y, and Shiraki K. Role of cardiac-renal neural reflex in regulating sodium excretion during water immersion in conscious dogs. J Physiol. 2002;545:305-312.
21. Petersson M, Friberg P, Eisenhofer G, et al. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J. 2005;26:906-913.
22. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. Jama. 2002;287:1541-1547.
23. Stevenson LW. Inotropic therapy for heart failure. N Engl J Med. 1998; 339:1848-1850.